Publications by authors named "Alan Fix"

Claim this Profile
S
Safety, immunogenicity, and relative efficacy of a parenteral trivalent rotavirus subunit vaccine candidate (TV P2-VP8) in healthy Ghanaian, Malawian, and Zambian infants.
Tushar Tewari, George Armah, Nigel A Cunliffe, Caroline C Chisenga, Desiree Witte, Alan Fix

Vaccine· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of novel live attenuated type 1 and type 3 oral poliomyelitis vaccines in healthy adults in the USA: a first-in-human, observer-masked, multicentre, phase 1 randomised controlled trial.
Laina D Mercer, Arlene C Seña, E Ross Colgate, Jessica W Crothers, Peter F Wright, Alan Fix

Lancet Infect Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in The Gambia: a phase 3, double-blind, randomised controlled trial.
Magnus Ochoge, Ahmed Cherno Futa, Ama Umesi, Lucy Affleck, Larry Kotei, Alan Fix

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between Immunogenicity of a Monovalent Parenteral P2-VP8 Subunit Rotavirus Vaccine and Fecal Shedding of Rotavirus following Rotarix Challenge during a Randomized, Double-Blind, Placebo-Controlled Trial.
Tamika Fellows, Nicola Page, Alan Fix, Jorge Flores, Stanley Cryz

Viruses· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine Trials.
Sally Hunsberger, Susan S Ellenberg, Steven Joffe, Abdel Babiker, Alan Fix

NEJM Evid· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Challenges and Opportunities of Next-Generation Rotavirus Vaccines: Summary of an Expert Meeting with Vaccine Developers.
Jessie Chen, Stephanie Grow, Miren Iturriza-Gómara, William P Hausdorff, Alan Fix

Viruses· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials.
Christopher Gast, Ananda S Bandyopadhyay, Xavier Sáez-Llorens, Tirza De Leon, Rodrigo DeAntonio, Alan Fix

J Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluating stability of attenuated Sabin and two novel type 2 oral poliovirus vaccines in children.
Rahnuma Wahid, Laina Mercer, Chris Gast, Tirza De Leon, Xavier Sáez-Llorens, Alan Fix

NPJ Vaccines· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data and Safety Monitoring of COVID-19 Vaccine Clinical Trials.
Steven Joffe, Abdel Babiker, Susan S Ellenberg, Alan Fix, Marie R Griffin

J Infect Dis· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials.
Xavier Sáez-Llorens, Ananda S Bandyopadhyay, Christopher Gast, Tirza De Leon, Rodrigo DeAntonio, Alan Fix

Lancet· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials.
Ilse De Coster, Isabel Leroux-Roels, Ananda S Bandyopadhyay, Christopher Gast, Kanchanamala Withanage, Alan Fix

Lancet· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation rotavirus vaccine developers meeting: Summary of a meeting sponsored by PATH and the bill & melinda gates foundation (19-20 June 2019, Geneva).
Alan Fix, Carl D Kirkwood, Duncan Steele, Jorge Flores

Vaccine· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a Controlled Human Infection Model with a Lyophilized Strain of Shigella sonnei 53G.
Robert W Frenck, Michelle Dickey, Akamol E Suvarnapunya, Lakshmi Chandrasekaran, Robert W Kaminski, Alan Fix

mSphere· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a parenteral trivalent P2-VP8 subunit rotavirus vaccine: a multisite, randomised, double-blind, placebo-controlled trial.
Michelle J Groome, Lee Fairlie, Julie Morrison, Alan Fix, Anthonet Koen

Lancet Infect Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I trial of WRSS1, a live oral vaccine in Bangladeshi adults and children.
Rubhana Raqib, Protim Sarker, K Zaman, Nur Haque Alam, Thomas F Wierzba, Alan Fix

Hum Vaccin Immunother· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial.
Firdausi Qadri, Marjahan Akhtar, Taufiqur R Bhuiyan, Mohiul I Chowdhury, Tasnuva Ahmed, Alan Fix

Lancet Infect Dis· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses.
Marjahan Akhtar, Mohiul I Chowdhury, Taufiqur R Bhuiyan, Joanna Kaim, Tasnuva Ahmed, Alan Fix

Vaccine· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Live attenuated enterotoxigenic Escherichia coli (ETEC) vaccine with dmLT adjuvant protects human volunteers against virulent experimental ETEC challenge.
Clayton Harro, A Louis Bourgeois, David Sack, Richard Walker, Barbara DeNearing, Alan Fix

Vaccine· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neutrophil Counts in Healthy South African Infants: Implications for Enrollment and Adverse Event Grading in Clinical Trials in an African Setting.
Anthonet Koen, Lisa Jose, Shabir A Madhi, Alan Fix, Stanley Cryz

J Pediatr X· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Prasad S Kulkarni, Sajjad Desai, Tushar Tewari, Anand Kawade, Nidhi Goyal, Alan Fix

Vaccine· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial.
Michelle J Groome, Anthonet Koen, Alan Fix, Nicola Page, Lisa Jose

Lancet Infect Dis· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immunogenicity of a parenterally administered rotavirus VP8 subunit vaccine in healthy adults.
Alan D Fix, Clayton Harro, Monica McNeal, Len Dally, Jorge Flores

Vaccine· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadening inclusion of vulnerable populations in HIV vaccine trials.
Chuen-Yen Lau, Massimo Cardinali, Paul A Sato, Alan Fix, Jorge Flores

Expert Rev Vaccines· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of Lyme disease.
Xinzhi Zhang, Martin I Meltzer, César A Peña, Annette B Hopkins, Lane Wroth, Alan D Fix

Emerg Infect Dis· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Active surveillance for acute viral hepatitis in rural villages in the Nile Delta.
Fatma A Meky, Sonia K Stoszek, Mohamed Abdel-Hamid, Sahar Selim, Ayman Abdel-Wahab, Alan D Fix

Clin Infect Dis· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis